Answer
The most common adverse reactions to Vyepti (eptinezumab) were nasopharyngitis and hypersensitivity, with most hypersensitivity reactions occurring during infusion and not being serious.
Sources for this answer
- Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked